Integrated Network Analysis of microRNAs, mRNAs, and Proteins Reveals the Regulatory Interaction between hsa-mir-200b and CFL2 Associated with Advanced Stage and Poor Prognosis in Patients with Intestinal Gastric Cancer
Open accessThe DOI matches its Crossref record; 83 of the 85 references it cites were found in a registry or an index.
Abstract
Intestinal gastric cancer (IGC) carcinogenesis results from a complex interplay between environmental and molecular factors, ultimately contributing to disease development. We used integrative bioinformatic analysis to investigate IGC high-throughput molecular data to uncover interactions among differentially expressed genes, microRNAs, and proteins and their roles in IGC. An integrated network was generated based on experimentally validated microRNA-gene/protein interaction data, with three regulatory circuits involved in a complex network contributing to IGC progression. Key regulators were determined, including 23 microRNA and 15 gene/protein hubs. The regulatory circuit networks were associated with hallmarks of cancer, e.g., cell death, apoptosis and the cell cycle, the immune response, and epithelial-to-mesenchymal transition, indicating that different mechanisms of gene regulation impact similar biological functions. Altered expression of hubs was related to the clinicopathological characteristics of IGC patients and showed good performance in discriminating tumors from adjacent nontumor tissues and in relation to T stage and overall survival (OS). Interestingly, expression of upregulated hub hsa-mir-200b and its downregulated target hub gene/protein CFL2 were related not only to pathological T staging and OS but also to changes during IGC carcinogenesis. Our study suggests that regulation of CFL2 by hsa-miR-200b is a dynamic process during tumor progression and that this control plays essential roles in IGC development. Overall, the results indicate that this regulatory interaction is an important component in IGC pathogenesis. Also, we identified a novel molecular interplay between microRNAs, proteins, and genes associated with IGC in a complex biological network and the hubs closely related to IGC carcinogenesis as potential biomarkers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures











Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Yuan, K., Li, B., Yuan, Y., Tan, M., Tan, J., Dai, W., Feng, W., & Zuo, J.-D. (2018) · Technology in Cancer Research & Treatment · doi:10.1177/1533033818806499 · Cited by 26 · cited 1×
“Furthermore, other studies reinforce that CFL2 regulation seems to be highly related to miRNA activity: CFL2 was identified as a validated target of miR-16 [80] and miR-375 [81].”
BackgroundRetractedXu, Q., Jia, X., Wu, Q., Shi, L., Ma, Z., Ba, N., Zhao, H., Xia, X., & Zhang, Z. (2020) · Oncology Letters · doi:10.3892/ol.2020.12193 · Cited by 20
RetractedSung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699 · cited 1×
“Gastric cancer (GC) has the fifth highest incidence and fourth highest mortality globally, with 1089.103 new cases and 768,793 related deaths in 2020 [1].”
BackgroundInfluentialModerated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 2×
“Sample normalization and DEG and DEM identification were performed using the DESeq2 (DESeq2, RRID:SCR_015687) [22] package.”
Cytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“The DEM–DEG–DEP regulatory network was constructed and visualized using Cytoscape (version 3.9.1) (Cytoscape, RRID:SCR_003032) [24].”
MethodInfluentialBartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Error and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-L. (2000) · Nature · doi:10.1038/35019019 · Cited by 7,534 · cited 1×
“This information is central not only to understanding the network structure but also to predicting the magnitude of changes that can occur if a given hub is subjected to management as they are important for network maintenance [39].”
BackgroundcytoHubba: identifying hub objects and sub-networks from complex interactome
Chin, C.-H., Chen, S.-H., Wu, H.-H., Ho, C.-W., Ko, M.-T., & Lin, C.-Y. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-s4-s11 · Cited by 6,562 · cited 2×
“The DEG/DEP hubs were chosen based on the top 5 nodes from the network identified by the maximal clique centrality (MCC) analysis method, which has good performance regarding prediction precision [29].”
MethodComprehensive molecular characterization of gastric adenocarcinoma
The Cancer Genome Atlas Research Network (2014) · Nature · doi:10.1038/nature13480 · Cited by 6,498 · cited 2×
“In 2014, The Cancer Genome Atlas (TCGA) program conducted a large study using high-throughput molecular approaches such as whole-exome sequencing and mRNA sequencing and was able to identify molecular subtypes of GC [15].”
MethodError and attack tolerance of complex networks
Albert, R., Jeong, H., & Barabási, A.-Ĺ. (2000) · RePEc: Research Papers in Economics · Cited by 6,469
LAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Basic principles of ROC analysis
Metz, C. E. (1978) · Seminars in Nuclear Medicine · doi:10.1016/s0001-2998(78)80014-2 · Cited by 6,026 · cited 1×
“AUC values of 90–100 = excellent, 80–90 = good, 70–80 = fair, 60–70 = poor, and 50–60 = failure [32,33].”
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Colaprico, A., Silva, T. C., Olsen, C., Garofano, L., Cava, C., Garolini, D., Sabedot, T. S., Malta, T. M., Pagnotta, S. M., Castiglioni, I., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1507 · Cited by 4,183 · cited 1×
“…the R software (version 3.6.1, https://www.r-project.org/, accessed on 5 March 2023) (R software, RRID:SCR_001905) using the package TCGAbiolinks (TCGAbiolinks, RRID:SCR_017683) [21] from R/Bioconductor (http://www.bioconductor.org/, accessed on 5 March 2023) (Bioconductor, RRID:SCR_006442).”
MethodInfluentialControlling the false discovery rate in behavior genetics research
Benjamini, Y., Drai, D., Elmer, G., Kafkafi, N., & Golani, I. (2001) · Behavioural Brain Research · doi:10.1016/s0166-4328(01)00297-2 · Cited by 4,146 · cited 1×
“These tools apply overrepresentation analysis (ORA), and the p value obtained was corrected using FDR from Benjamini-Hochberg adjustment [28] for each category independently, with significant categories being identified for adjusted p values ≤ 0.05.”
MethodInfluentialGene set knowledge discovery with enrichr
Xie, Z., Bailey, A., Kuleshov, M. V., Clarke, D. J. B., Evangelista, J. E., Jenkins, S. L., Lachmann, A., Wojciechowicz, M. L., Kropiwnicki, E., Jagodnik, K. M., et al. (2021) · Current Protocols · doi:10.1002/cpz1.90 · Cited by 3,451 · cited 1×
“Functional enrichment analysis of DEGs/DEPs was performed using Enrichr (RRID:SCR_001575) [25], and miRNA enrichment was performed using TAM 2.0: tool for microRNA set analysis [26,27].”
MethodInfluentialThe role of MicroRNAs in human cancer
Peng, Y., & Croce, C. M. (2016) · Signal Transduction and Targeted Therapy · doi:10.1038/sigtrans.2015.4 · Cited by 2,483
Gastric Cancer: Descriptive Epidemiology, Risk Factors, Screening, and Prevention
Karimi, P., Islami, F., Anandasabapathy, S., Freedman, N. D., & Kamangar, F. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-1057 · Cited by 1,879
Ru, Y., Kechris, K. J., Tabakoff, B., Hoffman, P., Radcliffe, R. A., Bowler, R., Mahaffey, S., Rossi, S., Calin, G. A., Bemis, L., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku631 · Cited by 800 · cited 1×
“To obtain DEM–DEG pairs, validated interactions between DEMs and target DEGs were acquired using the multiMiR [23] package, including 3 databases (miRecords, miRTar-Cancers Base, and TarBase) with available validated interactions.”
MethodMicroRNA Expression Profiles in Serous Ovarian Carcinoma
Nam, E. J., Yoon, H., Kim, S. W., Kim, H., Kim, Y. T., Kim, J. H., Kim, J. W., & Kim, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1731 · Cited by 740
Why Do Hubs Tend to Be Essential in Protein Networks?
He, X., & Zhang, J. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020088 · Cited by 701 · cited 1×
“It is known that deleting highly connected hubs has a high probability of lethality to organisms (centrality–lethality rule); this is due to its functional importance connecting several nodes related to multiple pathways in biological systems that makes them essential [38].”
BackgroundOptimalCutpoints: An R Package for Selecting Optimal Cutpoints in Diagnostic Tests
López-Ratón, M., Rodríguez-Álvarez, M. X., Suárez, C. C., & Sampedro, F. G. (2014) · Journal of Statistical Software · doi:10.18637/jss.v061.i08 · Cited by 548
Nagini, S. (2012) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v4.i7.156 · Cited by 509 · cited 1×
“Furthermore, surgical resection and chemotherapy have limited value in advanced-stage patients [2–5].”
BackgroundFunctions of cofilin in cell locomotion and invasion
Bravo-Cordero, J. J., Magalhaes, M. A. O., Eddy, R. J., Hodgson, L., & Condeelis, J. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3609 · Cited by 461
The LIN28/let-7 Pathway in Cancer
Balzeau, J., Menezes, M. R., Cao, S., & Hagan, J. P. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00031 · Cited by 447 · cited 1×
“They inhibit tumor growth and metastasis [49–51].”
Davalos, V, Moutinho, C., Villanueva, A., Boque, R., Silva, P., Carneiro, F., & Esteller, M. (2012) · Oncogene · doi:10.1038/onc.2011.383 · Cited by 351 · cited 1×
“The miR-200 family plays a major role in EMT and metastasis suppression by repressing ZEB1 (downregulated DEG in our study—Supplementary Table S2) and ZEB2, transcription factors that promote tumor invasion and metastasis by inducing EMT through E-cadherin repression [58,59].”
BackgroundDegree Distributions of Growing Networks
Krapivsky, P. L., Rodgers, G. J., & Redner, S. (2001) · Physical Review Letters · doi:10.1103/physrevlett.86.5401 · Cited by 312 · cited 1×
“This tool allows analysis of “direct networks”, extracting the number of direct interactions of regulators and targets, i.e., the out-degree for the regulators and the in-degree for the targets [30].”
MethodThe MicroRNA-17-92 Family of MicroRNA Clusters in Development and Disease
Concepcion, C. P., Bonetti, C., & Ventura, A. (2012) · The Cancer Journal · doi:10.1097/ppo.0b013e318258b60a · Cited by 285
Evidence Based Emergency Medicine; Part 5 Receiver Operating Curve and Area under the Curve.
Safari, S., Baratloo, A., Elfil, M., & Negida, A. (2016) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v4i2.232 · Cited by 253
Agrawal, P. B., Greenleaf, R. S., Tomczak, K. K., Lehtokari, V.-L., Wallgren-Pettersson, C., Wallefeld, W., Laing, N. G., Darras, B. T., Maciver, S. K., Dormitzer, P. R., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/510402 · Cited by 240
Yong, X., Tang, B., Li, B.-S., Xie, R., Hu, C.-J., Luo, G., Qin, Y., Dong, H., & Yang, S.-M. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0111-0 · Cited by 235 · cited 1×
“Furthermore, surgical resection and chemotherapy have limited value in advanced-stage patients [2–5].”
BackgroundCellular functions of the ADF/cofilin family at a glance
Kanellos, G., & Frame, M. C. (2016) · Journal of Cell Science · doi:10.1242/jcs.187849 · Cited by 223
TAM 2.0: tool for MicroRNA set analysis
Li, J., Han, X., Wan, Y., Zhang, S., Zhao, Y., Fan, R., Cui, Q., & Zhou, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky509 · Cited by 182
MicroRNAs and cancer stem cells: the sword and the shield
Sun, X., Jiao, X., Pestell, T. G., Fan, C., Qin, S., Mirabelli, E., Ren, H., & Pestell, R. G. (2014) · Oncogene · doi:10.1038/onc.2013.492 · Cited by 161 · cited 1×
“They inhibit tumor growth and metastasis [49–51].”
miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Tang, H., Deng, M., Tang, Y., Xie, X., Guo, J., Kong, Y., Ye, F., Su, Q., & Xie, X. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1326 · Cited by 160 · cited 1×
“In Asian populations, expression of hsa-miR-200c and mainly hsa-miR-200b is reported to be downregulated in GC tissues and related to poor OS [63–66].”
BackgroundCirculating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Valladares-Ayerbes, M., Reboredo, M., Medina-Villaamil, V., Iglesias-Díaz, P., Lorenzo-Patiño, M. J., Haz, M., Santamarina, I., Blanco, M., Fernández-Tajes, J., Quindós, M., et al. (2012) · Journal of Translational Medicine · doi:10.1186/1479-5876-10-186 · Cited by 153
Elson‐Schwab, I., Lorentzen, A., & Marshall, C. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013176 · Cited by 142
Luo, D., Wilson, J. M., Harvel, N., Liu, J., Pei, L., Huang, S., Hawthorn, L., & Shi, H. (2013) · Journal of Translational Medicine · doi:10.1186/1479-5876-11-57 · Cited by 142
TAM: A method for enrichment and depletion analysis of a microRNA category in a list of microRNAs
Lu, M., Shi, B., Wang, J., Cao, Q., & Cui, Q. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-419 · Cited by 130
Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review
Huang, Y., & Yu, J.-C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i34.9863 · Cited by 124 · cited 1×
“Furthermore, other studies reinforce that CFL2 regulation seems to be highly related to miRNA activity: CFL2 was identified as a validated target of miR-16 [80] and miR-375 [81].”
BackgroundTakeno, A., Takemasa, I., Doki, Y., Yamasaki, M., Miyata, H., Takiguchi, S., Fujiwara, Y., Matsubara, K., & Monden, M. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604682 · Cited by 102
A myriad of roles of miR-25 in health and disease
Sárközy, M., Kahán, Z., & Csont, T. (2018) · Oncotarget · doi:10.18632/oncotarget.24662 · Cited by 99
Let-7 microRNA as a potential therapeutic target with implications for immunotherapy
Gilles, M.-E., & Slack, F. J. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1535594 · Cited by 99 · cited 1×
“On the other hand, expression of the upregulated hsa-miR-let-7d of RRC2 increased with increasing T stage. miRNAs of the let-7 family are known for their tumor-suppressor functions and are commonly repressed in tumors [48].”
BackgroundAgrawal, P. B., Joshi, M., Savic, T., Chen, Z., & Beggs, A. H. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds053 · Cited by 99
Miller, T. E., Ulitsky, I., Hertzano, R. P., Rudnicki, A., Dror, A. A., Lenz, D. R., Elkon, R., Irmler, M., Beckers, J., Shamir, R., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018195 · Cited by 92
The Functions of MicroRNA-200 Family in Ovarian Cancer: Beyond Epithelial-Mesenchymal Transition
Choi, P., & Ng, S. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18061207 · Cited by 87
The insights of Let‐7 miRNAs in oncogenesis and stem cell potency
Sun, X., Liu, J., Xu, C., Tang, S., & Ren, H. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12861 · Cited by 83
Trümbach, D., & Prakash, N. (2014) · Cell and Tissue Research · doi:10.1007/s00441-014-1911-z · Cited by 82
Moh-Moh-Aung, A., Fujisawa, M., Ito, S., Katayama, H. G., Ohara, T., Ota, Y., Yoshimura, T., & Matsukawa, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-67425-4 · Cited by 72
Congenital myopathy caused by a novel missense mutation in the CFL2 gene
Ockeloen, C. W., Gilhuis, H. J., Pfundt, R., Kamsteeg, E., Agrawal, P. B., Beggs, A. H., Hama‐Amin, A. D., Diekstra, A., Knoers, N. V. A. M., Lammens, M. M. Y., et al. (2012) · Neuromuscular Disorders · doi:10.1016/j.nmd.2012.03.008 · Cited by 60
Overexpression of miR-15b-5p promotes gastric cancer metastasis by regulating PAQR3
Zhao, C., Li, Y., Chen, G., Wang, F., Shen, Z., & Zhou, R. (2017) · Oncology Reports · doi:10.3892/or.2017.5673 · Cited by 60 · cited 1×
“In GC, overexpression of hsa-miR-15b-5p has been verified to promote carcinogenesis, and a high plasma level of miR-15b-5p correlates with distant tumor metastasis [46].”
BackgroundIntegrated analysis of a ceRNA network reveals potential prognostic lncRNAs in gastric cancer
Qi, M., Yu, B., Yu, H., & Li, F. (2020) · Cancer Medicine · doi:10.1002/cam4.2760 · Cited by 59 · cited 1×
“…network of differentially expressed lncRNA–miRNA– mRNA in GC patients identified CFL2 as one of the downregulated genes targeted by hsa-miR-20a-5p (upregulated hub in RRC1 also targeting CFL2 —Supplementary Table S3) and hsa-miR-148a-3p (downregulated DEM in our work—Supplementary Table S3) [78].”
BackgroundWang, F., Ruan, L., Yang, J., Zhao, Q., & Wei, W. (2018) · Oncology Reports · doi:10.3892/or.2018.6750 · Cited by 56
Zhang, G., Li, J., Zhang, J., Liang, X., Zhang, X., Wang, T., & Yin, S. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001297 · Cited by 54
Seo, J., Jin, D., Choi, C.-H., & Lee, H. (2017) · PLoS ONE · doi:10.1371/journal.pone.0168412 · Cited by 48
Bi, J., Guo, A., Lai, R., Li, B., Zhong, J., Wu, H., Xie, Z., He, L., Lv, L., Lau, S., et al. (2010) · Neoplasma · doi:10.4149/neo_2010_03_191 · Cited by 48 · cited 1×
“In accordance with our results, hsa-miR-195-5p expression was significantly downregulated in the tissues and serum of GC patients [42]. hsa-miR-195-5p is related to regulation of the Wnt/ β -catenin pathway [42], the epithelial-to-mesenchymal transition [43], and multidrug resistance [44,45].”
ResultmiR‑195‑5p regulates multi‑drug resistance of gastric cancer cells via targeting ZNF139
Nie, H., Mu, J., Wang, J., & Li, Y. (2018) · Oncology Reports · doi:10.3892/or.2018.6524 · Cited by 48 · cited 1×
“In accordance with our results, hsa-miR-195-5p expression was significantly downregulated in the tissues and serum of GC patients [42]. hsa-miR-195-5p is related to regulation of the Wnt/ β -catenin pathway [42], the epithelial-to-mesenchymal transition [43], and multidrug resistance [44,45].”
ResultXiao, Y. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29194 · Cited by 43 · cited 1×
“In recent years, important studies integrating data from expression of mRNAs and microRNAs to identify microRNA targets have been performed in many cancer models [7–10] and in gastric cancer, e.g., prediction of interactions between mRNAs and noncoding RNAs [11–14].”
BackgroundExpression and clinical significance of the microRNA-200 family in gastric cancer.
Chang, L., Guo, F., Huo, B.-J., Lv, Y., Wang, Y.-D., & Liu, W. (2015) · Oncology Letters · doi:10.3892/ol.2015.3028 · Cited by 40
Bioinformatics Analysis of Key Genes and circRNA‐miRNA‐mRNA Regulatory Network in Gastric Cancer
Tian, Y., Yang, X., Zhang, Z., Peng, R., Zhang, L., & Sun, Y. (2020) · BioMed Research International · doi:10.1155/2020/2862701 · Cited by 40 · cited 15×
“The group was characterized by comparison between upregulated DEGs (2220) and upregulated DEPs (161), resulting in 16 common DEGs/DEPs (Figure 3B).”
BackgroundInfluentialWang, J., Zhang, M., Hu, X., She, J., Sun, R., Qin, S., & Li, D. (2021) · FEBS Open Bio · doi:10.1002/2211-5463.13125 · Cited by 40
Kuramitsu, Y. (2011) · Oncology Reports · doi:10.3892/or.2011.1447 · Cited by 35
Li, X., Yu, X., He, Y., Meng, Y., Liang, J., Huang, L., Du, H., Wang, X., & Liu, W. (2018) · BioMed Research International · doi:10.1155/2018/1972606 · Cited by 35
MicroRNA-200 family members and ZEB2 are associated with brain metastasis in gastric adenocarcinoma
Minn, Y., Lee, D. H., Hyung, W. J., Kim, J. E., Choi, J., Yang, S.-H., Song, H., Lim, B. J., & Kim, S. H. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2680 · Cited by 33 · cited 1×
“However, hsa-miR-200b and hsa-miR-200c are also upregulated in brain metastases in GC patients [67] and serum samples, where high levels of hsa-miR-200c are also related to short OS [68,69].”
BackgroundLi, Z., Qin, T., Wang, K., Hackenberg, M., Yan, J., Gao, Y., Yu, L., Shi, L. M., Su, Z., & Chen, T. (2015) · BMC Genomics · doi:10.1186/s12864-015-1516-2 · Cited by 30
Expression of tumor suppressors miR-195 and let-7a as potential biomarkers of invasive breast cancer
Marques, M. M. C., Evangelista, A. F., Macedo, T., Vieira, R. A. D. C., Scapulatempo‐Neto, C., Reis, R. M., Carvalho, A. L., & da Silva, I. D. C. G. (2018) · Clinics · doi:10.6061/clinics/2018/e184 · Cited by 30 · cited 1×
“The hub with high diagnostic potential was downregulated hsa-miR-195-5p (AUCs = 0.9409) in IRC. hsa-miR-195-5p downregulation has been found to be a potential biomarker for lung and breast cancer [40,41]; this DEM also has good potential as a biomarker in GC.”
BackgroundInfluentialMicroRNA Biomarker hsa-miR-195-5p for Detecting the Risk of Lung Cancer
Li, L., Feng, T., Zhang, W., Gao, S., Wang, R., Lv, W., Zhu, T., Yu, H., & Qian, B. (2020) · International Journal of Genomics · doi:10.1155/2020/7415909 · Cited by 29 · cited 1×
“The hub with high diagnostic potential was downregulated hsa-miR-195-5p (AUCs = 0.9409) in IRC. hsa-miR-195-5p downregulation has been found to be a potential biomarker for lung and breast cancer [40,41]; this DEM also has good potential as a biomarker in GC.”
BackgroundInfluentialBian, Y., Guo, J., Qiao, L., & Sun, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010236 · Cited by 29 · cited 2×
“…is supported by the findings in GC cell lines by Bian and colleagues [82], who verified that CFL2 knockdown inhibits proliferation and migration of MGC803 cells and that high CFL2 expression is associated with poor prognosis in patients with GC [82], demonstrating the oncogenic function of CFL2 .”
ResultCirc_0006404 Accelerates Prostate Cancer Progression Through Regulating miR-1299/CFL2 Signaling
Li, P., Wang, Z., Li, S., & Wang, L. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s277831 · Cited by 28 · cited 1×
“In breast cancer, upregulation of CFL2 was detected in aggressive cell lines and tissues [76]; similar findings were also observed in prostate cancer, promoting proliferation and migration in cell lines [77].”
BackgroundLoss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B/CDK8-STAT3 feedback loop
Xu, T., Xie, M., Jing, X., Jiang, H., Wu, X., Wang, X., & Shu, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03933-x · Cited by 25 · cited 1×
“In turn, significant downregulation of hsa-mir-26b-5p has been observed in Helicobacter pylori-infected GC cells and tissues, promoting proliferation in vitro and in vivo, and is related to poor outcome in GC patients [56].”
BackgroundIntegrated miRNA profiling and bioinformatics analyses reveal upregulated miRNAs in gastric cancer
Yuan, C., Zhang, Y., Tu, W., & Guo, Y. (2019) · Oncology Letters · doi:10.3892/ol.2019.10495 · Cited by 25
Li, D., & Li, Q. (2022) · Bioengineered · doi:10.1080/21655979.2022.2034585 · Cited by 23 · cited 1×
“In Asian populations, expression of hsa-miR-200c and mainly hsa-miR-200b is reported to be downregulated in GC tissues and related to poor OS [63–66].”
BackgroundZhao, D.-L., & Wu, Q. (2019) · PubMed · doi:10.26355/eurrev_201908_18532 · Cited by 22 · cited 1×
“In accordance with our results, hsa-miR-195-5p expression was significantly downregulated in the tissues and serum of GC patients [42]. hsa-miR-195-5p is related to regulation of the Wnt/ β -catenin pathway [42], the epithelial-to-mesenchymal transition [43], and multidrug resistance [44,45].”
ResultBottai, G., Diao, L., Baggerly, K., Paladini, L., Győrffy, B., Raschioni, C., Pusztai, L., Călin, G. A., & Santarpia, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010194 · Cited by 20
Liu, Y., Xu, Y., Xiao, F., Zhang, J., Wang, Y., Yao, Y., & Jie-wen, Y. (2020) · Mediators of Inflammation · doi:10.1155/2020/9435608 · Cited by 19
Gastric Cancer Pre-Stage Detection and Early Diagnosis of Gastritis Using Serum Protein Signatures
Aziz, S., Rasheed, F., Zahra, R., & König, S. (2022) · Molecules · doi:10.3390/molecules27092857 · Cited by 19 · cited 1×
“Corroborating our data, high expression of small nuclear ribonucleoprotein Sm D1 ( SNRPD1 ) was found at both the gene [54] and protein levels (in serum) [55] in GC.”
ResultPrognostic value of candidate microRNAs in gastric cancer: A validation study
Zhang, L., Huang, Z., Zhang, H., Zhu, M., Zhu, W., Xin Min, Z. H. O. U., & Liu, P. (2016) · Cancer Biomarkers · doi:10.3233/cbm-160091 · Cited by 17 · cited 1×
“However, hsa-miR-200b and hsa-miR-200c are also upregulated in brain metastases in GC patients [67] and serum samples, where high levels of hsa-miR-200c are also related to short OS [68,69].”
BackgroundSilencing of PRDM5 increases cell proliferation and inhibits cell apoptosis in glioma
Wang, X., Chang, H., Gao, G., Su, B., Deng, Q., Zhou, H., Wang, Q., Lin, Y., & Ding, Y. (2020) · International Journal of Neuroscience · doi:10.1080/00207454.2020.1733563 · Cited by 16
Zhu, T., Lou, Q., Shi, Z., & Chen, G. (2021) · Europe PMC (PubMed Central) · Cited by 14
Hu, S., Liao, Y., Zheng, J., Gou, L., Regmi, A., Zafar, M. I., & Chen, L. (2019) · BioMed Research International · doi:10.1155/2019/2725192 · Cited by 12
Hsa-let-7d-5p Promotes Gastric Cancer Progression by Targeting PRDM5
Gao, X., Liu, H., Wang, R., Huang, M., Wu, Q., Wang, Y., Zhang, W., & Liu, Y. (2022) · Journal of Oncology · doi:10.1155/2022/2700651 · Cited by 11
Xu, T., Xie, F., Xu, D., Xu, W., Ge, X.-M., Lv, S., & Li, S. (2021) · Journal of Oncology · doi:10.1155/2021/4470778 · Cited by 10
Santos, E. C., Binato, R., Fernandes, P. V., Ferreira, M. A., & Abdelhay, E. (2022) · Cancer Biomarkers · doi:10.3233/cbm-203225 · Cited by 9 · cited 3×
“A total of 429 DEPs were identified [20].”
BackgroundMethodInfluentialSelf-citationGastric Carcinoma: A Review on Epidemiology, Current Surgical and Chemotherapeutic Options
Rokkappanavar, K., Sajjan, S., Esaki, M., et al. (2013) · InTech eBooks · doi:10.5772/52138 · Cited by 4
Cited by
Matsuoka, T., & Yashiro, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115880 · Cited by 83
“Another study examining intestinal GC molecular networks’ gene-microRNA relationship has shown that three regulatory circuits are identified in a complex interaction network [38].”
BackgroundLi, P., Huang, Y., Jiang, W., Zheng, H., Chen, R., & Ding, X. (2026) · Future Oncology · doi:10.1080/14796694.2026.2631302 · Cited by 2
Liu, Y., Wang, Z., Liu, W., Li, P., Chen, J., Shi, Z., & Ye, J. (2026) · Future Science OA · doi:10.1080/20565623.2026.2702980
“…expression levels are reportedly upregulated in prostate and gastric cancers, with this abnormal pattern associated with the disease pathogenesis [26,27]. elevated cFl2 expression serves as a predictive biomarker for radiotherapy resistance and represents a potential therapeutic target for…”
Metadata
- Authors
- dos Santos, E. C., Rohan, P., Binato, R., & Abdelhay, E.
- Affiliations
- Instituto Nacional de Câncer - INCA (BR)
- Corresponding author
- dos Santos, Everton Cruz
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2023-11-12
- Volume
- 15
- Issue
- 22
- Pages
- 5374
- ISSN
- 2072-6694 (ISSN-L)
- PMC
- PMC10670725
- OpenAlex
- W4388637464
- Cited by
- 3
- References
- 85
- Citations by year
- 2026: 2 · 2024: 1
- FWCI
- 0.38
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancers (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro (E-26/202.981/2016, SEI-260003/001147/2020, 303479/2015)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) (E-26/202.981/2016, SEI-260003/001147/2020, 303479/2015)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- regulatory networks, hub genes, tumor progression, T staging, overall survival, prognostic factors, carcinogenesis, epithelial-mesenchymal transition, cancer hallmarks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.